Euro Accident is a leading Swedish specialist in health-related insurance and employee wellbeing, active primarily within the long-term disability, pension risk and private health insurance. Euro Accident was founded in 1996 and has experienced strong growth over the past 15 years, enabled by high quality products and leading service that aim at keeping their clients as healthy as possible. Today more than half a million people in Sweden are insured through the company.
Impilo together with management and a group of other investors have agreed to acquire Euro Accident from the current owners National General Holdings Corp., a specialty personal lines insurance company listed on NASDAQ (NGHC). The transaction is subject to customary regulatory approvals and is expected to close late in 2019.
Read moreNews
Scantox Group acquires Gentronix
Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”), well recognized for its high-quality genetic toxicology services and strong scientific engagement.
Impilo acquires Qufora in partnership with existing shareholders
Impilo is now the majority shareholder in the Danish medtech company Qufora, which produces clinical aids for patients with chronic bowel conditions. This partnership will enable Qufora to accelerate its international expansion.
KKR and Impilo announce strategic partnership together with management in rare disease platform Immedica Pharma
Stockholm and London, 23 April 2024 – Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Existing owner, Nordic healthcare investment firm Impilo, will reinvest to become an equal owner alongside KKR. The transaction is subject to customary regulatory and closing conditions.